Recurrent membranoproliferative glomerulonephritis after kidney transplantation

Elizabeth C. Lorenz, Sanjeev M Sethi, Nelson Leung, Angela Dispenzieri, Fernando Custodio Fervenza, Fernando G Cosio

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

On examination of the records of 1321 patients following kidney transplant over an 11-year period, we found that 29 patients had recurrent membranoproliferative glomerulonephritis (MPGN). We excluded from this analysis patients who had MPGN type II, those with clear evidence of secondary MPGN, and those lacking post-transplant biopsies. During an average of 53 months of follow-up, we found using protocol biopsies that 12 of these patients had recurrent MPGN diagnosed 1 week to 14 months post-transplant. In 4 of the 12 patients this presented clinically, whereas the remaining had subclinical disease. The risk of recurrence was significantly increased in patients with low complement levels. Serum monoclonal proteins were found in a total of six patients; appeared to be associated with earlier, more aggressive disease; and were more common in recurrent than non-recurrent disease. The recurrence of MPGN was marginally higher in recipients of living-donor kidneys. Some patients developed characteristic lesions within 2 months post-transplant, whereas others presented with minimal, atypical histological changes that progressed to MPGN. Of 29 patients, 5 lost their allograft and 2 patients remain on chronic plasmapheresis. Our study shows the risk of MPGN recurrence and progression depends on identifiable pretransplant characteristics, has variable clinical impact, and can result in graft failure.

Original languageEnglish (US)
Pages (from-to)721-728
Number of pages8
JournalKidney International
Volume77
Issue number8
DOIs
StatePublished - Apr 2010

Fingerprint

Membranoproliferative Glomerulonephritis
Kidney Transplantation
Transplants
Recurrence
Kidney
Biopsy
Plasmapheresis
Living Donors
Allografts
Blood Proteins

Keywords

  • Glomerulonephritis
  • Kidney transplantation
  • Membranoproliferative glomerulonephritis (MPGN)
  • Monoclonal gammopathy
  • Transplant pathology

ASJC Scopus subject areas

  • Nephrology

Cite this

Recurrent membranoproliferative glomerulonephritis after kidney transplantation. / Lorenz, Elizabeth C.; Sethi, Sanjeev M; Leung, Nelson; Dispenzieri, Angela; Fervenza, Fernando Custodio; Cosio, Fernando G.

In: Kidney International, Vol. 77, No. 8, 04.2010, p. 721-728.

Research output: Contribution to journalArticle

@article{1237879881ac434692a752678d570a6f,
title = "Recurrent membranoproliferative glomerulonephritis after kidney transplantation",
abstract = "On examination of the records of 1321 patients following kidney transplant over an 11-year period, we found that 29 patients had recurrent membranoproliferative glomerulonephritis (MPGN). We excluded from this analysis patients who had MPGN type II, those with clear evidence of secondary MPGN, and those lacking post-transplant biopsies. During an average of 53 months of follow-up, we found using protocol biopsies that 12 of these patients had recurrent MPGN diagnosed 1 week to 14 months post-transplant. In 4 of the 12 patients this presented clinically, whereas the remaining had subclinical disease. The risk of recurrence was significantly increased in patients with low complement levels. Serum monoclonal proteins were found in a total of six patients; appeared to be associated with earlier, more aggressive disease; and were more common in recurrent than non-recurrent disease. The recurrence of MPGN was marginally higher in recipients of living-donor kidneys. Some patients developed characteristic lesions within 2 months post-transplant, whereas others presented with minimal, atypical histological changes that progressed to MPGN. Of 29 patients, 5 lost their allograft and 2 patients remain on chronic plasmapheresis. Our study shows the risk of MPGN recurrence and progression depends on identifiable pretransplant characteristics, has variable clinical impact, and can result in graft failure.",
keywords = "Glomerulonephritis, Kidney transplantation, Membranoproliferative glomerulonephritis (MPGN), Monoclonal gammopathy, Transplant pathology",
author = "Lorenz, {Elizabeth C.} and Sethi, {Sanjeev M} and Nelson Leung and Angela Dispenzieri and Fervenza, {Fernando Custodio} and Cosio, {Fernando G}",
year = "2010",
month = "4",
doi = "10.1038/ki.2010.1",
language = "English (US)",
volume = "77",
pages = "721--728",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Recurrent membranoproliferative glomerulonephritis after kidney transplantation

AU - Lorenz, Elizabeth C.

AU - Sethi, Sanjeev M

AU - Leung, Nelson

AU - Dispenzieri, Angela

AU - Fervenza, Fernando Custodio

AU - Cosio, Fernando G

PY - 2010/4

Y1 - 2010/4

N2 - On examination of the records of 1321 patients following kidney transplant over an 11-year period, we found that 29 patients had recurrent membranoproliferative glomerulonephritis (MPGN). We excluded from this analysis patients who had MPGN type II, those with clear evidence of secondary MPGN, and those lacking post-transplant biopsies. During an average of 53 months of follow-up, we found using protocol biopsies that 12 of these patients had recurrent MPGN diagnosed 1 week to 14 months post-transplant. In 4 of the 12 patients this presented clinically, whereas the remaining had subclinical disease. The risk of recurrence was significantly increased in patients with low complement levels. Serum monoclonal proteins were found in a total of six patients; appeared to be associated with earlier, more aggressive disease; and were more common in recurrent than non-recurrent disease. The recurrence of MPGN was marginally higher in recipients of living-donor kidneys. Some patients developed characteristic lesions within 2 months post-transplant, whereas others presented with minimal, atypical histological changes that progressed to MPGN. Of 29 patients, 5 lost their allograft and 2 patients remain on chronic plasmapheresis. Our study shows the risk of MPGN recurrence and progression depends on identifiable pretransplant characteristics, has variable clinical impact, and can result in graft failure.

AB - On examination of the records of 1321 patients following kidney transplant over an 11-year period, we found that 29 patients had recurrent membranoproliferative glomerulonephritis (MPGN). We excluded from this analysis patients who had MPGN type II, those with clear evidence of secondary MPGN, and those lacking post-transplant biopsies. During an average of 53 months of follow-up, we found using protocol biopsies that 12 of these patients had recurrent MPGN diagnosed 1 week to 14 months post-transplant. In 4 of the 12 patients this presented clinically, whereas the remaining had subclinical disease. The risk of recurrence was significantly increased in patients with low complement levels. Serum monoclonal proteins were found in a total of six patients; appeared to be associated with earlier, more aggressive disease; and were more common in recurrent than non-recurrent disease. The recurrence of MPGN was marginally higher in recipients of living-donor kidneys. Some patients developed characteristic lesions within 2 months post-transplant, whereas others presented with minimal, atypical histological changes that progressed to MPGN. Of 29 patients, 5 lost their allograft and 2 patients remain on chronic plasmapheresis. Our study shows the risk of MPGN recurrence and progression depends on identifiable pretransplant characteristics, has variable clinical impact, and can result in graft failure.

KW - Glomerulonephritis

KW - Kidney transplantation

KW - Membranoproliferative glomerulonephritis (MPGN)

KW - Monoclonal gammopathy

KW - Transplant pathology

UR - http://www.scopus.com/inward/record.url?scp=77950521571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950521571&partnerID=8YFLogxK

U2 - 10.1038/ki.2010.1

DO - 10.1038/ki.2010.1

M3 - Article

C2 - 20130531

AN - SCOPUS:77950521571

VL - 77

SP - 721

EP - 728

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 8

ER -